Primary Research Platforms

Tufts CSDD has a very robust annual research agenda. We typically conduct 15 to 20 new grant-funded studies across four primary research platforms: overall drug development performance and economics; clinical trial design and execution; clinical research manufacturing and logistics; and medical and regulatory affairs. These studies are typically funded by individual sponsors or multiple sponsors participating as part of a working group.    
Learn more about our Research Platforms and Working Groups

Recurrent Assessments

Organizations also provide funding for Tufts CSDD to perform benchmark, return on investment (ROI) and expected net present value (ENPV) assessments, and listening sessions among clinical research professionals.
Learn more about our Recurrent Research Assessments

Longitudinal Studies

Every five to seven years, Tufts CSDD conducts seminal longitudinal studies to monitor and update trends in drug development landscape, practices, and economics. These longitudinal studies are typically funded by general donations and support.
Learn more about our Longitudinal Studies